Sorrento Therapeutics Overview

Sorrento Therapeutics Gross Profit

Gross Profit analysis for SRNE.

Quarterly Gross Profit

$6.57M

↑ 14.16% YoY

As of Jun 30, 2023

Annual Gross Profit (TTM)

$28.64M

↓ 22.59% YoY

Trailing 12 months ending Jun 30, 2023

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin